Gianluca Quaglio
Gianluca Quaglio works in the European Parliament Research Service (EPRS) as policy analyst in health and research policies sectors. He obtained a degree in Medicine from Verona University and a PhD in International Health at the Maastricht University. Before he joined the EPRS, he worked as a clinician and clinical researcher at Verona University Hospital and as scientific project officer in the European Commission, DG Research. He has published over a hundred articles in international peer-review scientific journals.-
Dexamethasone : the first life-saving drug for COVID-19 patients
Clinical trials make it possible to evaluate whether a treatment improves outcomes. Developing a hypothesis, for example if treatment A is better than standard treatment B, clinical trials enable understanding of the role of an intervention in improving patient care. In the current search for a successful...
-
A scientist’s opinion : Interview with Prof Martin Landray about covid-19 treatment
Interview with Martin Landray, Professor of Medicine and Epidemiology at the Nuffield Department of Population Health, University of Oxford, Oxford, UK. He is one of the main researchers participating in the Recovery study on dexamethasone. The study was published in the New England Journal of Medicine...